Zydus Lifesciences shares rise 5% on acquisition news
after close1 source ↓written by the desknot a recommendation
- to ₹985.70
- 4.95%
- over the past
- 5% increase
- since the start
- 8% rise
- to discuss
- 19 May 2023
Zydus Lifesciences' shares surged 4.95% to ₹985.70 on the NSE after announcing a definitive agreement to acquire Asserto Holdings, Inc. This marks a 5% increase over the past month and an 8% rise since the start of the year. The board will also meet on 19 May 2023 to discuss a potential buyback proposal.
Not investment advice. For informational purposes only.